ClinConnect ClinConnect Logo
Search / Trial NCT04694885

Quality of Life Improvement During Chemotherapy

Launched by CHRISTIAN SCHWEGLER · Jan 4, 2021

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Breast Cancer Chemotherapy Hypnotherapy Hypnosis Quality Of Life Anxiety Depression Immunity Dose Response Effect

ClinConnect Summary

This clinical trial, taking place at the University Hospital Basel, is studying how structured hypnotherapy can improve the quality of life for women undergoing chemotherapy for breast cancer. The trial involves two groups: one group will receive 10 sessions of hypnotherapy along with their usual cancer treatment, while the other group will only receive the standard treatment without any additional therapy. Researchers want to see if the women who have hypnotherapy feel better overall, experience fewer side effects from chemotherapy, and have less anxiety and depression.

To participate in this trial, women must be at least 18 years old, diagnosed with primary breast cancer, and currently receiving chemotherapy. However, those with certain psychological disorders or cognitive issues that might interfere with the study will not be eligible. Participants can expect no risks from the hypnotherapy sessions, and if the study shows positive results, this treatment could be included in future care for breast cancer patients.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Minimum Age 18 years
  • Female
  • Primary breast cancer
  • Receiving neo-adjuvant or adjuvant chemotherapy
  • Exclusion Criteria:
  • Verbal or cognitive deficits that are not compatible with outpatient psychotherapy
  • Not consenting patients and vulnerable persons
  • Psychological disorders that prevent patients from participating in the study (e.g. psychotic disorder)
  • acute suicidality

About Christian Schwegler

Christian Schwegler is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes. With a focus on innovative therapeutic solutions, Schwegler's initiatives span various therapeutic areas, emphasizing rigorous study design and adherence to ethical standards. By fostering collaboration among healthcare professionals, researchers, and regulatory bodies, he aims to facilitate the efficient development of safe and effective treatments. Schwegler's expertise in clinical trial management and his proactive approach to stakeholder engagement ensure the successful execution of trials that contribute to the body of medical knowledge and enhance patient care.

Locations

Basel, Basel Stadt, Switzerland

Patients applied

0 patients applied

Trial Officials

Isabel Ge, Dr.

Study Director

University Hospital, Basel, Switzerland

Christian Schwegler, Dr.

Principal Investigator

University Hospital, Basel, Switzerland

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials